The rationale behind PERK inhibition was that chronic overactivation of PERK in tauopathies may lead to a disadvantageous long‐term suppression of translation by phosphorylation of EIF2A (Radford et al, 2015). This evidence concerns the gene EIF2A and tauopathy.